Q1 2026

Filed May 1, 2026 · 10-Q · 31 days after period end · 0000785161-26-000130

Q1 2026 · 10-Q

Revenue

$1.59B

+9.0% vs Q1 2025

Net Income

$194.50M

+28.4% vs Q1 2025

EPS Diluted

$1.93

+30.4% vs Q1 2025

Operating Cash Flow$313,100,000+8.5%

Free Cash Flow

Same quarter

Metric	Q1 2026	Q1 2025	Q1 2024	Q1 2023
Revenue	$1.59B	$1.46B	$1.32B	$1.16B
Net Income	$194.50M	$151.50M	$112.50M	$87.70M
EPS Diluted	$1.93	$1.48	$1.10	$0.87

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Encompass Health Corp · CIK 785161 · Engraved from SEC EDGAR